Eric C. Strain, MD; Maxine L. Stitzer, PhD; Ira A. Liebson, MD; George E. Bigelow, PhD
To compare the dose effectiveness of low to moderate doses of methadone in a sample of a contemporary population of opioid abusers, because the optimal dosing of methadone in the treatment of opioid dependence remains an issue.
A randomized, double-blind, placebo-controlled study.
A methadone treatment research clinic.
Participants (n = 247) were opioid-dependent patients with a high rate of cocaine use.
All participants were initially treated with active methadone for a minimum of 5 weeks and then received 15 weeks of stable dosing at 50, 20, or 0 mg per day. Individual counseling and group therapy were included.
Treatment retention and illicit drug use as determined by intensive urine monitoring.
Retention was better for patients who remained on active medication. By treatment week 20, retention was 52.4% for the 50-mg, 41.5% for the 20-mg, and 21.0% for the 0-mg group (50 versus 0 and 20 versus 0, P < 0.05; 50 versus 20, P > 0.05). Only the 50-mg treatment group had a reduced rate of opioid-positive urine samples (56.4% versus 67.6% and 73.6% for the 20-mg and 0-mg groups, respectively; P < 0.05) and cocaine-positive urine samples (52.6% versus 62.4% and 67.1% for the 20- and 0-mg groups, respectively; P < 0.05).
There is a dose-response effect for methadone treatment. Doses as low as 20 mg may improve retention but are inadequate for suppressing illicit drug use.
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Dose-Response Effects of Methadone in the Treatment of Opioid Dependence. Ann Intern Med. ;119:23–27. doi: 10.7326/0003-4819-119-1-199307010-00004
Download citation file:
Published: Ann Intern Med. 1993;119(1):23-27.
Tobacco, Alcohol, and Other Substance Abuse.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use